Related Experiment Video

Updated: May 31, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Synthetic lethality-based targets for discovery of new cancer therapeutics

Ulrich H Weidle1, Daniela Maisel, Dirk Eick

  • 1Roche Diagnostics, Division Pharma, Penzberg, Germany. ulrich.weidle@roche.com

Cancer Genomics & Proteomics
|July 9, 2011
PubMed

Insights

Synthetic lethality exploits the loss of two or more genes for cancer cell death, offering a targeted therapy. This approach enhances anticancer drug efficacy by targeting cancer-specific genetic vulnerabilities.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Synthetic lethality is a genetic interaction where the simultaneous loss of two or more genes leads to cell death, unlike the loss of a single gene.
  • Cancer cells often exhibit genetic alterations, including mutations and deregulation, creating vulnerabilities exploitable by synthetic lethality strategies.
  • Targeting these synthetic lethal interactions can significantly improve therapeutic efficacy and broaden the therapeutic window in cancer treatment.

Purpose of the Study:

  • To review the concept of synthetic lethality in the context of cancer therapy.
  • To discuss specific genetic vulnerabilities targeted by synthetic lethality, including DNA repair deficiencies, RAS mutations, tumor suppressor gene loss (p53, Rb, VHL), and disrupted protein kinase networks.
  • To explore the development of novel anticancer agents based on synthetic lethality principles.

Main Methods:

  • Review of existing literature on synthetic lethality and its application in oncology.
  • Analysis of specific genetic alterations and pathways relevant to synthetic lethality.
  • Discussion of preclinical and clinical strategies for developing synthetic lethality-based anticancer drugs.

Main Results:

  • Synthetic lethality offers a promising strategy for targeted cancer therapy by exploiting the incompatibility of cell survival with the loss of multiple genes.
  • Deficient DNA repair mechanisms, activating RAS mutations, loss of function in tumor suppressor genes (p53, Rb, VHL), and disrupted protein kinase networks are key targets.
  • These targets create specific vulnerabilities in cancer cells that can be exploited for therapeutic gain.

Conclusions:

  • Synthetic lethality presents a powerful paradigm for developing novel anticancer agents with enhanced efficacy and improved therapeutic windows.
  • The strategy holds significant potential for treating cancers with specific genetic profiles.
  • Further research into synthetic lethal interactions will drive the development of next-generation cancer therapies.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...